Gt Biopharma, INC. (GTBP) — S-1 Filings
All S-1 filings from Gt Biopharma, INC.. Browse 3 IPO Filing reports with AI-powered summaries and risk analysis.
S-1 Filings (3)
-
GT Biopharma Registers 14.6M Shares for Resale, Cites Going Concern Doubt
— Oct 24, 2025 Risk: high
GT Biopharma, Inc. (GTBP) filed an S-1 to register 14,589,546 shares of common stock for resale by selling stockholders, stemming from a May 2025 private placem -
GT Biopharma Files S-1 Registration
— Dec 23, 2024 Risk: medium
GT Biopharma, Inc. filed an S-1 registration statement with the SEC on December 23, 2024. The company, previously known as OXIS INTERNATIONAL INC, DDI PHARMACEU -
GT Biopharma Files S-1 Registration Statement
— Jun 20, 2024 Risk: medium
GT Biopharma, Inc. filed an S-1 registration statement on June 18, 2024, to register securities. The company, formerly known as OXIS INTERNATIONAL INC, DDI PHAR
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX